drugset / Trial / NCT05503901
A Long Term Study of STN1012600 in Subjects With Open Angle Glaucoma or Ocular Hypertension
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate safety and the ocular hypotensive effect of STN1012600 ophthalmic solution 0.002% alone or in combination with Timolol ophthalmic solution 0.5% for 52 weeks in subjects with open angle glaucoma or ocular hypertension.
Timeline
- Start
- 2022-08-08
- Primary completion
- 2024-01-30
- Completion
- 2024-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sepetaprost | Small molecule | 0.002 % | Other |
| Subject | Timolol | Other / unclassified | 0.5 % | Other |